| Authors: |
Robu S; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany; stephanie.robu@tum.de., Richter A; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Gosmann D; School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Seidl C; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Leung D; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Hayes W; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Cohen D; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Morin P; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Donnelly DJ; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Lipovšek D; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Bonacorsi SJ; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Smith A; Bristol-Myers Squibb Research and Development, Princeton, New Jersey., Steiger K; Institute of Pathology, School of Medicine, Technical University of Munich, Munich, Germany.; German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and., Aulehner C; School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany., Krackhardt AM; School of Medicine, Clinic and Policlinic for Internal Medicine III, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and., Weber WA; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; German Cancer Consortium, Munich, Germany, and German Cancer Research Center, Heidelberg, Germany; and.; TranslaTUM (Zentralinstitut für translationale Krebsforschung der Technischen Universität München), Munich, Germany. |
